✦ LIBER ✦

Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy

✍ Scribed by Giorgio Capuano; Alessandra Grosso; Pier Carlo Gentile; Michele Battista; Federico Bianciardi; Annamaria Di Palma; Ida Pavese; Francesco Satta; Michela Tosti; Anna Palladino; Guido Coiro; Mario Di Palma

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 134 KB
Volume: 30
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20737

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

The purpose of this study was to determine the influence of weight loss on outcome in patients with head and neck cancer undergoing concomitant chemoradiotherapy (CCRT): treatment interruption, infections, mortality, and hospital readmission rate.

Methods.

Forty patients with head and neck cancer were enrolled. All patients were counseled to follow a nutritional program during CCRT. Body weight was evaluated at baseline, at the end, and 30 days after radiochemotherapy.

Results.

Ninety percent of compliant patients with nutritional program maintained body weight (mean, 1 ± 2.4 kg) and 100% of noncompliant patients continued to lose weight (mean, −9 ± 4 kg; p < .001). A reduction greater than 20% of prediagnosis weight significantly correlated with treatment interruption (p = .003), infections (p = .002), early mortality (p = .011), hospital readmission rate (p = .001), and survival (log‐rank test: z = −2.722, p = .006).

Conclusion.

📜 SIMILAR VOLUMES

Quality of life as predictor of weight l

Quality of life as predictor of weight loss in patients with head and neck cancer

✍ Karin M. Petruson; Ewa M. Silander; Eva B. Hammerlid 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Background. The purpose of this prospective study was to evaluate whether a relationship exists between malnutrition (≥10% weight loss) and health‐related quality of life (HRQL) in patients with head and neck cancer and whether weight loss can be predicted with HRQL questionnaires.

Predictors of weight loss during radioth

Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer

✍ Alice Nourissat; Isabelle Bairati; Elodie Samson; André Fortin; Michel Gélinas; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

## Abstract ## BACKGROUND: The purpose of the study was to identify predictors of weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer. ## METHODS: This study was conducted as part of a phase 3 chemoprevention trial. A total of 540 patients were randomize

Outcome of patients treated with cobalt

Outcome of patients treated with cobalt and 6 MV in head and neck cancers

✍ André Fortin; Josée Allard; Michele Albert; Jean Roy 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Influence of social support on health-re

Influence of social support on health-related quality of life outcomes in head and neck cancer

✍ Lucy Hynds Karnell; Alan J. Christensen; Eben L. Rosenthal; J. Scott Magnuson; G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract ## Background. Evidence that social support influences health‐related quality of life (HRQOL) in oncologic patients could be particularly important for head and neck cancer because this disease can affect speech, eating, and facial aesthetics. ## Methods. Multiple regression analyses

Randomized phase 2 study of concomitant

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##

Mechanisms of immune suppression in pati

Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer

✍ M. Rita I. Young; Mark A. Wright; Yvonne Lozano; John P. Matthews; Janet Benefie 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 789 KB

Freshly excised human head and neck cancers (2 I9 primary cancers; 64 metastatic lymph node cancers) were analyzed for the immune inhibitory mediators released from the cancer tissues and the immune infiltrate within the tumor. Significant levels of the immune inhibitory mediators transforming growt